- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4375 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine
Patent holdings for IPC class A61K 31/4375
Total number of patents in this class: 3752
10-year publication summary
|
203
|
186
|
244
|
231
|
225
|
242
|
249
|
275
|
341
|
274
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Deciphera Pharmaceuticals, LLC | 227 |
68 |
| Novartis AG | 10635 |
59 |
| Incyte Corporation | 1036 |
51 |
| Immunomedics, Inc. | 260 |
44 |
| F. Hoffmann-La Roche AG | 7931 |
43 |
| Bristol-myers Squibb Company | 4833 |
42 |
| Merck Sharp & Dohme LLC | 3735 |
40 |
| Merck Patent GmbH | 5758 |
37 |
| Bayer Pharma AG | 1048 |
36 |
| Boehringer Ingelheim International GmbH | 4644 |
35 |
| Bayer AG | 3385 |
29 |
| Hoffmann-La Roche Inc. | 3523 |
28 |
| Takeda Pharmaceutical Company Limited | 2719 |
27 |
| Gilead Sciences, Inc. | 2083 |
27 |
| Pliant Therapeutics, Inc. | 70 |
27 |
| Pfizer Inc. | 3403 |
26 |
| Shenzhen HighTide Biopharmaceutical, Ltd. | 58 |
26 |
| Genentech, Inc. | 4006 |
23 |
| Neurocrine Biosciences, Inc. | 427 |
23 |
| Merck Sharp & Dohme Corp. | 2190 |
22 |
| Other owners | 3039 |